Chiome Bioscience Inc. Stock

Equities

4583

JP3205350006

Biotechnology & Medical Research

Delayed Japan Exchange 02:00:00 2024-07-19 EDT 5-day change 1st Jan Change
127 JPY -1.55% Intraday chart for Chiome Bioscience Inc. +4.10% -5.93%
Dynamic Chart
Chiome Bioscience Cancels License Agreements with ADC Therapeutics MT
Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited CI
Chiome Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Chiome Bioscience Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Chiome Bioscience Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Chiome Bioscience Inc. announced that it has received ¥13.49304 million in funding from Barclays Bank PLC (Tokyo Branch), Growth Capital, Inc. CI
Chiome Bioscience Inc. announced that it expects to receive ¥13.49304 million in funding CI
Chiome Bioscience Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Chiome Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Chiome Bioscience Inc. Provided Sales Guidance for 2023 CI
Henlius Biotech Terminates License Agreement for Chiome Bioscience's Tumor Drug MT
Chiome Bioscience Inc. Announces Termination of the License Agreement for Anti-TROP-2 Antibody Development and Commercialization with Shanghai Henlius Biotech, Inc CI
Chiome Bioscience Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Chiome Bioscience Reports Results of Cancer Immunotherapy Joint Research MT
Chiome Bioscience Signs Research and Option Agreement with Heidelberg Pharma MT
More news
1 day-1.55%
1 week+4.10%
Current month-9.29%
6 months-8.63%
Current year-5.93%
More quotes
1 week
120.00
Extreme 120
133.00
1 month
111.00
Extreme 111
142.00
Current year
111.00
Extreme 111
174.00
1 year
111.00
Extreme 111
180.00
3 years
111.00
Extreme 111
325.00
5 years
111.00
Extreme 111
484.00
10 years
111.00
Extreme 111
2 020.00
More quotes
Managers TitleAgeSince
President 70 09-03-31
Director/Board Member 46 12-12-31
Members of the board TitleAgeSince
Director/Board Member 79 17-02-28
Director/Board Member 74 19-03-27
President 70 09-03-31
More insiders
Date Price Change Volume
24-07-19 127 -1.55% 442 000
24-07-18 129 -1.53% 500,400
24-07-17 131 +7.38% 942,200
24-07-16 122 0.00% 241,500
24-07-12 122 +3.39% 610,400

Delayed Quote Japan Exchange, July 19, 2024 at 02:00 am

More quotes
Chiome Bioscience Inc. is a company mainly engaged in the research and development of antibody drugs, and the provision of development support services. The Company operates in two business segments. The Drug Discovery segment is engaged in the research and development of specific antibodies based on new antigens and mechanisms and licensing to pharmaceutical companies. The Drug Discovery Support segment is engaged in development of lead antibodies for therapeutic drugs in collaborating with pharmaceutical companies in Japan and overseas.
Calendar
More about the company